CPhI Orphan Drugs 2014

Key Topics

• Key Game Changers Altering the Dynamic of the Orphan Drug Industry for Developers
• Orphan Drugs Reducing Impact of Revenue Loss from Patent Expiries of Blockbuster Drugs
• Promoting Orphan Drugs in Asia
• How Can Manufacturers Meet the Unmet Needs of Patients with Rare Diseases in the Region
• Patent Protection Be Used To Expand the Scope Of Protection
• Attract Investors and Investments into the Region
• Collaboration of Stakeholders in the Supply Chain to Ensure Accessibility of Orphan Drugs to Patients
• Right Pricing to Continue to Treat Patients and Remain Commercially Viable for Developers
• How Can R&D and Market Access Departments Pool Resources to Succeed in the Orphan Market?
• How Can Developers Access Patients with the Surmounting Number of Barriers?
• How Can Developers and Patients Collaborate to Steer the Development of Orphan Drugs?
• Reinforcing the Orphan Market for a Sustainable Future
• Ensuring the Success of the Partnership in the Orphan Market
• What Strategies are Available to Support the Development of Ultra Orphan Drugs?

Who should Attend

Representative from hospitals, government, biopharmaceuticals, pharmaceuticals, orphan drugs developers, non-profit organisations, policies, regional and local manufacturers to discuss and share on the macroeconomic factors, issues and drivers that will steer the development of orphan drugs into the region.